Anbio BiotechnologyNNNN
13F holders, Q3 2025 (September 30)10holders +5
5new positions
0sold out
1famous investor
$37.24avg. 13F price*
At the end of Q3 2025, 10 institutions reported holding Anbio Biotechnology Ltd. (NNNN) in their 13F filings, up 5 from Q2 2025. 5 opened new positions and 0 sold out. The largest holders were Geode Capital Management, LLC ($960K), Marshall Wace, LLP ($389K) and Morgan Stanley ($321K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Anbio Biotechnology Ltd.
- CUSIP
- G0367B105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $1.1M |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 48,454 shares bought and 9,735 shares sold, net +38,719 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Geode Capital Management, LLC | 0.00% | Add +50.4% | 25,763 | $960K |
| Marshall Wace, LLP | 0.00% | New | 10,443 | $389K |
| Morgan Stanley | 0.00% | Add +2052.5% | 8,610 | $321K |
| Millennium Management | 0.00% | New | 7,080 | $264K |
| XTX Topco Ltd | 0.01% | New | 6,896 | $257K |
| HRT Financial LP | 0.00% | New | 6,013 | $223K |
| BNP Paribas Financial Markets | 0.00% | Add +91.8% | 2,419 | $90K |
| UBS Group AG | 0.00% | Reduce -91.0% | 960 | $36K |
| Wells Fargo & Company | 0.00% | No change | 100 | $4K |
| Bank of America Corp. | 0.00% | New | 21 | $782 |
"% of holder's portfolio" is NNNN's weight in each manager's 13F, not the share of Anbio Biotechnology Ltd. the manager owns.